Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| BRIGHT (202430045) | Other Grant/Funding Number | Tsinghua University, Beijing, China. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Debre Berhan University | OTHER |
Not provided
Not provided
Not provided
Maternal and neonatal health remains one of the most pressing global health challenges, particularly in low- and middle-income countries (LMICs). Ethiopia continues to face a high burden, with maternal mortality estimated at 195 per 100,000 live births, neonatal mortality at 27 per 1,000 live births, and perinatal mortality rates ranging from 37‰ to 124‰ depending on the level of care. These outcomes remain substantially higher than the targets set under the United Nations Sustainable Development Goals (SDGs) for 2030.
The World Health Organization (WHO) recommends that all pregnant women receive at least one ultrasound scan before 24 weeks of gestation, yet nearly two-thirds of women worldwide-especially in LMICs-lack access to this service. Barriers include high costs of ultrasound machines, limited technical expertise, and shortages of skilled sonographers in rural primary care.
Artificial Intelligence-driven Point-of-Care Ultrasound (AI-POCUS) represents a promising innovation to expand prenatal imaging in resource-constrained settings by equipping frontline health workers with AI-supported diagnostic capabilities. This study, conducted under the Tsinghua University BRIGHT (Bringing Research to Impact for Global Health at Tsinghua) program, will evaluate the clinical effectiveness, feasibility, cost, and scalability of AI-POCUS in rural Ethiopia. A three-arm cluster randomized controlled trial will compare two AI-enabled ultrasound technologies-BabyChecker (Netherlands) and a China-developed AI-POCUS device-against standard antenatal care without ultrasound. Findings will generate robust clinical and policy-relevant evidence to guide the sustainable implementation of AI-enabled maternal health interventions in sub-Saharan Africa.
Maternal and neonatal morbidity and mortality remain unacceptably high in sub-Saharan Africa and continue to impede progress toward global health targets. In Ethiopia, recent estimates show maternal mortality at 195 per 100,000 live births and neonatal mortality at 27 per 1,000 live births. Perinatal mortality is also elevated, ranging between 66‰ and 124‰ in hospital-based settings and 37‰ to 52‰ in community-level health facilities. These figures surpass the Sustainable Development Goal (SDG) thresholds for 2030, underscoring the urgent need for innovative, scalable solutions.
Ultrasound imaging is a cornerstone of modern antenatal care. The WHO recommends at least one ultrasound before 24 weeks' gestation to assess gestational age, detect multiple pregnancies, identify fetal anomalies, and diagnose high-risk conditions such as preeclampsia, placenta previa, or growth restriction. However, nearly two-thirds of pregnant women worldwide still lack access to this basic diagnostic tool. In low-resource environments, the barriers include limited infrastructure, high equipment costs, technical complexity, and the scarcity of trained professionals capable of performing and interpreting scans. As a result, potentially preventable maternal and neonatal deaths remain common.
Artificial Intelligence-driven Point-of-Care Ultrasound (AI-POCUS) introduces a transformative opportunity to address these gaps. POCUS devices embedded with AI algorithms can guide non-specialist health workers in image acquisition and interpretation, reducing reliance on highly trained personnel and lowering barriers to integration within primary care. Such innovations may strengthen early detection of pregnancy complications, enable timely referral to higher-level care, and ultimately improve maternal and neonatal survival.
This study is embedded within the Bringing Research to Impact for Global Health at Tsinghua (BRIGHT) initiative. It will use a three-arm cluster randomized controlled trial (C-RCT) design to evaluate and compare: (1) BabyChecker, a portable AI-enabled ultrasound developed in the Netherlands, (2) A China-developed AI-POCUS device, and (3) Standard antenatal care (ANC) without ultrasound, reflecting current practice in many rural Ethiopian communities.
The study population will include pregnant women receiving antenatal care in rural Ethiopia, as well as primary health care providers delivering these services. Data will be collected at both the patient and facility level to capture maternal and neonatal health outcomes, health service utilization, and system-level performance indicators.
Evaluation will follow a multi-dimensional framework, addressing:
The study aims to provide rigorous clinical evidence and practical implementation guidance on how AI-POCUS technologies can be sustainably scaled in resource-constrained settings. Findings are expected to inform national health policies, guide investment decisions, and offer a replicable model for expanding maternal health technologies across sub-Saharan Africa and other LMICs.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Standard Care Control | No Intervention | Participants in this arm will receive routine antenatal care (ANC) according to Ethiopian national guidelines, without the use of AI-POCUS devices. All examinations, screenings, and referrals will be conducted through standard clinical practice. This group serves as the baseline comparator for evaluating the added impact of AI-POCUS technology. | |
| BabyChecker (Delft Imaging, Netherlands) | Experimental | Health centers in this arm will be equipped with the BabyChecker system developed by Delft Imaging (Netherlands). The portable device integrates fetal position, amniotic fluid volume, and biparietal diameter measurements, and provides diagnostic suggestions and risk alerts. After brief training, primary healthcare workers will independently perform antenatal examinations, screen for obstetric complications, and make referral decisions. |
|
| AI-POCUS (Edan, China) | Experimental | This arm will use the AI-POCUS device developed by Edan (China), designed to analyze blind ultrasound sweeps and automatically extract fetal diagnostic parameters. The system supports the early detection of maternal and fetal risks and assists in clinical decision-making. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| AI-POCUS (BabyChecker, Delft Imaging) | Device | A portable AI-driven ultrasound system developed by Delft Imaging (Netherlands). The device integrates fetal position, amniotic fluid volume, and biparietal diameter measurements, with built-in diagnostic suggestions and risk alerts. Primary healthcare workers, after brief training, use it for antenatal screening, complication detection, and referral decision-making. |
| Measure | Description | Time Frame |
|---|---|---|
| Maternal Mortality Ratio | Maternal deaths per 100,000 live births, defined as deaths occurring during pregnancy or within 42 days postpartum due to pregnancy-related causes. | Baseline through 42 days postpartum |
| Stillbirth Rate / Perinatal Mortality Rate | Stillbirths (≥28 weeks gestation) per 1,000 total births, and perinatal mortality including stillbirths and neonatal deaths within the first 7 days of life. | Delivery through 7 days postpartum |
| Early Neonatal Mortality Rate | Neonatal deaths within the first 7 days of life per 1,000 live births. | Birth through 7 days postpartum |
| Preterm Birth Rate | Proportion of births before 37 completed weeks of gestation, subdivided into extremely preterm (<32 weeks), very preterm (32-33 weeks), and late preterm (34-36 weeks). | At delivery |
| Maternal and Neonatal Referral Rate | Proportion of mothers or newborns referred to higher-level hospitals due to severe complications. | Antenatal period through 42 days postpartum |
| Congenital Anomaly Rate | Proportion of infants with major structural anomalies detected by prenatal ultrasound or confirmed postnatally (e.g., neural tube defects, limb malformations, cleft lip/palate). | Antenatal period through delivery |
| Measure | Description | Time Frame |
|---|---|---|
| Completion of ≥4/8 Antenatal Care (ANC) Visits | Proportion of pregnant women who completed at least 4 of 8 ANC visits, respectively, during pregnancy, according to WHO recommendations. | Pregnancy through delivery |
| High-Risk Pregnancy Detection Rate |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Yuxuan LI, Doctoral Candidate | Contact | +86-18813076657 | li-yx23@mails.tsinghua.edu.cn |
| Name | Affiliation | Role |
|---|---|---|
| Kun TANG, Associate Professor | Tsinghua University | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hakim Gizaw Hospital | Debre Berhan | Amhara | 1000 | Ethiopia |
Undecided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D011248 | Pregnancy Complications |
| D047928 | Premature Birth |
| D005317 | Fetal Growth Retardation |
| D050497 | Stillbirth |
| D005313 | Fetal Death |
| ID | Term |
|---|---|
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D007752 | Obstetric Labor, Premature |
| D007744 | Obstetric Labor Complications |
Not provided
Not provided
This study will employ a cluster randomized controlled trial design, with primary health care centers serving as the cluster (intervention) units and individual pregnant women as the primary observational units. A total of nine health centers will be selected and matched based on geographic location, maternal mortality rates, and the service capacity of health care personnel. The matched health centers will then be randomly assigned in a 1:1:1 ratio to one of three study arms, with each arm including three health centers.
A total of 1,059 pregnant women will be recruited, with 353 participants per study arm. Interventions will be implemented at the cluster level, while outcomes - including maternal and neonatal health indicators - will be assessed at the individual participant level. This design allows for the evaluation of the effectiveness and feasibility of AI-POCUS interventions while accounting for intra-cluster correlation and contextual variability across health centers.
Not provided
Not provided
Other parties masked in this trial include the data analysts, who will remain blinded to group assignments during statistical analyses to minimize bias in outcome assessment.
|
| AI-POCUS (Edan, China) | Device | An AI-POCUS device developed by Edan (China), capable of analyzing blind ultrasound sweeps to extract fetal diagnostic parameters and assist in early risk identification. It supports clinical decision-making for antenatal care. |
|
Proportion of pregnant women identified as high-risk (e.g., placenta previa, malpresentation) by AI-POCUS or conventional ultrasound, divided by total enrolled women.
| Pregnancy through delivery |
| High-Risk Pregnancy Follow-Up Completion Rate | Among women identified as high-risk, proportion who completed at least 1 or 2 follow-up ANC visits. | Pregnancy through delivery |
| Referral Completion Rate After Screening | Proportion of women meeting high-risk pregnancy criteria who successfully completed referral to a higher-level hospital. | Pregnancy through delivery |
| D005315 | Fetal Diseases |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D006130 | Growth Disorders |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D003643 | Death |